[1] Perumpail BJ, Khan MA, Yoo ER, et al. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2017, 23: 8263-8276.
[2] 刘琪,张玉梅. 非酒精性脂肪肝与认知功能障碍的研究进展[J]. 中华老年心脑血管病杂志,2021,23(10):1115-1117.
[3] 许旌, 杨立, 师璇, 等. 老年非酒精性脂肪性肝病患者100例的认知功能观察和临床特点[J]. 中华消化杂志, 2019, 39(1):35-39.
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志,2018,34(5):641-649.
[5] Yilmaz Y, Ozdogan O. Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue[J]. Hepatology, 2009, 49(2):698.
[6] Filipović B, Marković O, Ðuri, et al. Cognitive changes and brain volume reduction in patients with nonalcoholic fatty liver disease[J]. Can J Gastroenterol Hepatol, 2018,2018:9638797.
[7] Seo SW, Gottesman RF, Clark JM, et al. Nonalcoholic fatty liver disease is associated with cognitive function in aduts[J]. Neurology,2016,86(12):1136-1142.
[8] 倪力, 范建高. 铁超载与非酒精性脂肪性肝病[J].实用肝脏病杂志, 2013, 16(6):574-576.
[9] 许旌, 杨帆, 师璇, 等. 老年非酒精性脂肪性肝病患者认知功能损害的相关性研究[J]. 中华内分泌代谢杂志, 2020, 36(10):832-837.
[10] Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis[J]. Curr Opin Gastroenterol, 2005, 21(6):702-707.
[11] Solís Herruzo JA, García Ruiz I, Pérez Carreras M, et al. Nonalcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction[J]. Rev Esp Enferm Dig,2006,98(11):844-74.
[12] Dhanda S, Gupta S, Halder A, et al. Systemic inflammation without gliosis mediates cognitive deficits through impaired BDNF expression in bile duct ligation model of hepatic encephalopathy[J]. Brain Behav Immun,2018,70:214-232.
[13] 李海霞, 蔡玉芳, 马金辉. 老年冠心病病人血清可溶性转铁蛋白受体水平与认知功能的关系[J]. 中西医结合心脑血管病杂志, 2021, 19(14):2367-2370.
[14] 许旌, 张洪, 杨帆, 等. 老年2型糖尿病患者铁代谢与认知功能的相关性分析[J]. 中华内分泌代谢杂志, 2019, 35(4):302-306.
[15] 王萍,唐光才,舒健,等.非酒精性脂肪肝肝/CT值与血脂的关系研究[J]. 西南医科大学学报 , 2018, 41: 67-70 .
[16] Power MC, Rawlings A, Sharrett AR, et al. Association of midlife lipids with 20-year cognitive change: A cohort study[J]. Alzheimers Dement, 2018, 14(2): 167-177. |